FR2376664A1 - Derive l-prolinamide et son utilisation comme moyen therapeutique pour le traitement des maladies des yeux - Google Patents

Derive l-prolinamide et son utilisation comme moyen therapeutique pour le traitement des maladies des yeux

Info

Publication number
FR2376664A1
FR2376664A1 FR7800169A FR7800169A FR2376664A1 FR 2376664 A1 FR2376664 A1 FR 2376664A1 FR 7800169 A FR7800169 A FR 7800169A FR 7800169 A FR7800169 A FR 7800169A FR 2376664 A1 FR2376664 A1 FR 2376664A1
Authority
FR
France
Prior art keywords
treatment
eye diseases
hormone
therapeutic medium
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7800169A
Other languages
English (en)
French (fr)
Other versions
FR2376664B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2376664A1 publication Critical patent/FR2376664A1/fr
Application granted granted Critical
Publication of FR2376664B1 publication Critical patent/FR2376664B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/066—TRH, thyroliberin, thyrotropin releasing hormone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7800169A 1977-01-05 1978-01-04 Derive l-prolinamide et son utilisation comme moyen therapeutique pour le traitement des maladies des yeux Granted FR2376664A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52000499A JPS6047244B2 (ja) 1977-01-05 1977-01-05 薬剤

Publications (2)

Publication Number Publication Date
FR2376664A1 true FR2376664A1 (fr) 1978-08-04
FR2376664B1 FR2376664B1 (enrdf_load_stackoverflow) 1982-10-15

Family

ID=11475440

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7800169A Granted FR2376664A1 (fr) 1977-01-05 1978-01-04 Derive l-prolinamide et son utilisation comme moyen therapeutique pour le traitement des maladies des yeux

Country Status (6)

Country Link
US (1) US4150120A (enrdf_load_stackoverflow)
JP (1) JPS6047244B2 (enrdf_load_stackoverflow)
DE (1) DE2800108A1 (enrdf_load_stackoverflow)
FR (1) FR2376664A1 (enrdf_load_stackoverflow)
GB (1) GB1596180A (enrdf_load_stackoverflow)
NL (1) NL7800065A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665089A (en) * 1985-03-21 1987-05-12 Massachusetts Institute Of Technology Process for preventing or reversing cataract formation using protein modification reagents
CN1011118B (zh) * 1986-06-13 1991-01-09 天津医学院附属医院 治疗白内障的眼药水的制药方法
JP2020510023A (ja) 2017-03-09 2020-04-02 ダイアメディカ， インコーポレイテッド 組織カリクレイン１の剤形

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262997A1 (en) * 1974-03-07 1975-10-03 Hoechst Ag Psychotropic medicaments contg. (pyro)-Glue-His-Pro-amide - and thymoleptics, monoaminoxidase inhibitors or neuroleptics
US3932623A (en) * 1974-06-18 1976-01-13 Wilson Ian C Method of treating schizophrenia
FR2323397A1 (fr) * 1975-09-09 1977-04-08 Takeda Chemical Industries Ltd Composition medicinale a base d'hormones
US4059692A (en) * 1975-04-03 1977-11-22 Takeda Chemical Industries, Ltd. Treating impaired consciousness with glutamyl-L-histidyl-L-prolinamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3746697A (en) * 1969-09-19 1973-07-17 K Folkers Tripeptide having the activity of the thyrotropin releasing hormone

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262997A1 (en) * 1974-03-07 1975-10-03 Hoechst Ag Psychotropic medicaments contg. (pyro)-Glue-His-Pro-amide - and thymoleptics, monoaminoxidase inhibitors or neuroleptics
US3932623A (en) * 1974-06-18 1976-01-13 Wilson Ian C Method of treating schizophrenia
US4059692A (en) * 1975-04-03 1977-11-22 Takeda Chemical Industries, Ltd. Treating impaired consciousness with glutamyl-L-histidyl-L-prolinamide
FR2323397A1 (fr) * 1975-09-09 1977-04-08 Takeda Chemical Industries Ltd Composition medicinale a base d'hormones

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CA1973 *
CA1974 *
CA1975 *

Also Published As

Publication number Publication date
JPS6047244B2 (ja) 1985-10-21
FR2376664B1 (enrdf_load_stackoverflow) 1982-10-15
NL7800065A (nl) 1978-07-07
US4150120A (en) 1979-04-17
GB1596180A (en) 1981-08-19
DE2800108A1 (de) 1978-07-13
JPS5386009A (en) 1978-07-29

Similar Documents

Publication Publication Date Title
Neistadt et al. Effects of electrical stimulation of the carotid sinus nerve in reversal of experimentally induced hypertension
FR2433344A1 (fr) Appareil d'infusion implantable et procede d'infusion
EA199700213A1 (ru) Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений
BE844544A (fr) Insert ophtalmique pour le traitement du syndrome de l'oeil sec
Forell et al. The influence of bile and pure bile salts on pancreatic secretion in man
ATE273009T1 (de) Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel
EP0600930A4 (en) DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES.
FR2397192A1 (fr) Inhibition par peptides de la fonction des gonades
FR2450605A1 (fr) Composition pour traiter la cavite orale et procede de preparation
FR2450107A1 (fr) Nouvelles compositions detergentes cosmetiques et pharmaceutiques a base de sarcosine
ATE202557T1 (de) 15-fluoro-prostaglandine als augendrucksenkende mittel
FR2376664A1 (fr) Derive l-prolinamide et son utilisation comme moyen therapeutique pour le traitement des maladies des yeux
DE3853898D1 (de) Behandlung der RNase L-Defizienz mit ds RNS.
Sears et al. Changes in outflow facility and content of norepinephrine in iris and ciliary processes of albino rabbits after cervical ganglionectomy
FR2386304A1 (fr) Appareil medical pour soulager une thrombose des veines profondes
IT1148189B (it) 1-(p-2-isopropossietossimetil-fenossi)-3-isopropilammino-propan-2-olo e suoi sali per l'abbassamento della pressione endooculare e preparati oftalmici che li contengono
Rosenthal Alterations in serum thyroxine with cerebral electrotherapy (electrosleep)
Ong et al. Comparison of GABA-induced responses in various segments of the guinea-pig intestine
Ramer et al. Ocular penetration of pilocarpine: the effect of pH on the ocular penetration of pilocarpine
KR930702015A (ko) 각막 장해 치료제
Smolin Cellular response to inflammation at the limbus
DE69723670D1 (de) Zellwachstumshemmende zusammensetzungen die kalzium-zufluss-blocker enthalten
SU1033137A1 (ru) Способ лечени герпетических кератитов
Mahaux et al. THE EFFECT OF TRIIODOTHYRONINE ON CERVICAL LYMPHOID STRUCTURES, THYROID ACTIVITY, IgG AND IgM IMMUNOGLOBULIN LEVEL AND EXOPHTHALMOS IN GRAVES'DISEASE
NO963911D0 (no) Innretning for behandling av autoimmune sykdommer og fremgangsmåte for behandling

Legal Events

Date Code Title Description
ST Notification of lapse